Merck Appoints Simon Sturge as New Head of Biosimilars Unit

Merck Appoints Simon Sturge as New Head of Biosimilars Unit

[at noodls] – Darmstadt, Germany, February 20, 2014 – Merck announced today that Simon Sturge (54) will join the company from Boehringer Ingelheim effective March 1, 2014, to head the biosimilars unit. In his new role … more

View todays social media effects on MRK

View the latest stocks trending across Twitter. Click to view dashboard

See who Merck is hiring next, click here to view

Share this post